Dr. Arshin Sheybani, MD

Claim this profile

UnityPoint Health

Studies Cancer
Studies Squamous Cell Carcinoma
1 reported clinical trial
1 drug studied

Affiliated Hospitals

Image of trial facility.
Unity Point Health

Clinical Trials Arshin Sheybani, MD is currently running

More about Arshin Sheybani, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Arshin Sheybani, MD has experience with
  • DaRT224
Breakdown of trials Arshin Sheybani, MD has run
Squamous Cell Carcinoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arshin Sheybani, MD specialize in?
Arshin Sheybani, MD focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved treating patients, or patients who are undergoing treatment.
Is Arshin Sheybani, MD currently recruiting for clinical trials?
Yes, Arshin Sheybani, MD is currently recruiting for 1 clinical trial in Des Moines Iowa. If you're interested in participating, you should apply.
Are there any treatments that Arshin Sheybani, MD has studied deeply?
Yes, Arshin Sheybani, MD has studied treatments such as DaRT224.
What is the best way to schedule an appointment with Arshin Sheybani, MD?
Apply for one of the trials that Arshin Sheybani, MD is conducting.
What is the office address of Arshin Sheybani, MD?
The office of Arshin Sheybani, MD is located at: UnityPoint Health, Des Moines, Iowa 50309 United States. This is the address for their practice at the UnityPoint Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.